368 related articles for article (PubMed ID: 29763808)
1. Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds.
Jalili-Baleh L; Forootanfar H; Küçükkılınç TT; Nadri H; Abdolahi Z; Ameri A; Jafari M; Ayazgok B; Baeeri M; Rahimifard M; Abbas Bukhari SN; Abdollahi M; Ganjali MR; Emami S; Khoobi M; Foroumadi A
Eur J Med Chem; 2018 May; 152():600-614. PubMed ID: 29763808
[TBL] [Abstract][Full Text] [Related]
2. Novel 3-phenylcoumarin-lipoic acid conjugates as multi-functional agents for potential treatment of Alzheimer's disease.
Jalili-Baleh L; Nadri H; Forootanfar H; Samzadeh-Kermani A; Küçükkılınç TT; Ayazgok B; Rahimifard M; Baeeri M; Doostmohammadi M; Firoozpour L; Bukhari SNA; Abdollahi M; Ganjali MR; Emami S; Khoobi M; Foroumadi A
Bioorg Chem; 2018 Sep; 79():223-234. PubMed ID: 29775948
[TBL] [Abstract][Full Text] [Related]
3. Chromone-lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities.
Jalili-Baleh L; Nadri H; Forootanfar H; Küçükkılınç TT; Ayazgök B; Sharifzadeh M; Rahimifard M; Baeeri M; Abdollahi M; Foroumadi A; Khoobi M
Daru; 2021 Jun; 29(1):23-38. PubMed ID: 33420969
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease.
Lan JS; Ding Y; Liu Y; Kang P; Hou JW; Zhang XY; Xie SS; Zhang T
Eur J Med Chem; 2017 Oct; 139():48-59. PubMed ID: 28797883
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Jiang N; Huang Q; Liu J; Liang N; Li Q; Li Q; Xie SS
Eur J Med Chem; 2018 Feb; 146():287-298. PubMed ID: 29407958
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and evaluation of pterostilbene β-amino alcohol derivatives as multifunctional agents for Alzheimer's disease treatment.
Zheng Y; Qiang X; Xu R; Song Q; Tian C; Liu H; Li W; Tan Z; Deng Y
Bioorg Chem; 2018 Aug; 78():298-306. PubMed ID: 29625269
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and evaluation of salicyladimine derivatives as multitarget-directed ligands against Alzheimer's disease.
Yang HL; Cai P; Liu QH; Yang XL; Fang SQ; Tang YW; Wang C; Wang XB; Kong LY
Bioorg Med Chem; 2017 Nov; 25(21):5917-5928. PubMed ID: 28988627
[TBL] [Abstract][Full Text] [Related]
8. New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease.
Jalili-Baleh L; Nadri H; Moradi A; Bukhari SNA; Shakibaie M; Jafari M; Golshani M; Homayouni Moghadam F; Firoozpour L; Asadipour A; Emami S; Khoobi M; Foroumadi A
Eur J Med Chem; 2017 Oct; 139():280-289. PubMed ID: 28803044
[TBL] [Abstract][Full Text] [Related]
9. New coumarin-benzotriazole based hybrid molecules as inhibitors of acetylcholinesterase and amyloid aggregation.
Singh A; Sharma S; Arora S; Attri S; Kaur P; Kaur Gulati H; Bhagat K; Kumar N; Singh H; Vir Singh J; Mohinder Singh Bedi P
Bioorg Med Chem Lett; 2020 Oct; 30(20):127477. PubMed ID: 32781220
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and evaluation of chalcone-Vitamin E-donepezil hybrids as multi-target-directed ligands for the treatment of Alzheimer's disease.
Sang Z; Song Q; Cao Z; Deng Y; Zhang L
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):69-85. PubMed ID: 34894968
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Qiang X; Li Y; Yuan W; Liu Q; Shi Y; Ang W; Luo Y; Tan Z; Deng Y
Eur J Med Chem; 2015 Apr; 94():348-66. PubMed ID: 25778991
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.
Xie SS; Wang XB; Li JY; Yang L; Kong LY
Eur J Med Chem; 2013 Jun; 64():540-53. PubMed ID: 23685572
[TBL] [Abstract][Full Text] [Related]
13. 3-Aryl Coumarin Derivatives Bearing Aminoalkoxy Moiety as Multi-Target-Directed Ligands against Alzheimer's Disease.
Abdshahzadeh H; Golshani M; Nadri H; Saberi Kia I; Abdolahi Z; Forootanfar H; Ameri A; Tüylü Küçükkılınç T; Ayazgok B; Jalili-Baleh L; Sadat Ebrahimi SE; Moghimi S; Haririan I; Khoobi M; Foroumadi A
Chem Biodivers; 2019 May; 16(5):e1800436. PubMed ID: 30957958
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer's disease.
Lan JS; Hou JW; Liu Y; Ding Y; Zhang Y; Li L; Zhang T
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):776-788. PubMed ID: 28585866
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Wang K; Shi J; Liu W; Tan Z
Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
[TBL] [Abstract][Full Text] [Related]
17. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
Li Y; Qiang X; Li Y; Yang X; Luo L; Xiao G; Cao Z; Tan Z; Deng Y
Bioorg Med Chem Lett; 2016 Apr; 26(8):2035-9. PubMed ID: 26947607
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and evaluation of coumarin-pargyline hybrids as novel dual inhibitors of monoamine oxidases and amyloid-β aggregation for the treatment of Alzheimer's disease.
Yang HL; Cai P; Liu QH; Yang XL; Li F; Wang J; Wu JJ; Wang XB; Kong LY
Eur J Med Chem; 2017 Sep; 138():715-728. PubMed ID: 28728104
[TBL] [Abstract][Full Text] [Related]
19. New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease.
El-Sayed NF; El-Hussieny M; Ewies EF; Fouad MA; Boulos LS
Bioorg Chem; 2020 Jan; 95():103499. PubMed ID: 31838287
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of scutellarein-O-acetamidoalkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Qiang X; Li Y; Xu R; Cao Z; Song Q; Wang T; Zhang X; Liu H; Tan Z; Deng Y
Eur J Med Chem; 2017 Jul; 135():307-323. PubMed ID: 28458136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]